{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:39:17Z","timestamp":1783021157818,"version":"3.54.6"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ijid.2025.108231","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T08:45:58Z","timestamp":1763628358000},"page":"108231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Cytomegalovirus DNAemia in the lower respiratory tract in nontransplant patients with hematologic malignancies"],"prefix":"10.1016","volume":"163","author":[{"given":"Alicja","family":"Sadowska-Klasa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Be\u0142dzi\u0144ska-G\u0105dek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaja","family":"Klein-Awerjanow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Naumiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Maciej","family":"Zaucha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijid.2025.108231_bib0001","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/S2352-3026(15)00289-6","article-title":"Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study","volume":"3","author":"Green","year":"2016","journal-title":"Lancet Haematol"},{"issue":"Suppl 2","key":"10.1016\/j.ijid.2025.108231_bib0002","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1007\/s00277-003-0772-4","article-title":"Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies\u2013guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)","volume":"82","author":"Einsele","year":"2003","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.ijid.2025.108231_bib0003","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41408-023-00853-3","article-title":"Global burden of hematologic malignancies and evolution patterns over the past 30 years","volume":"13","author":"Zhang","year":"2023","journal-title":"Blood Cancer J"},{"issue":"7","key":"10.1016\/j.ijid.2025.108231_bib0004","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1182\/blood.2024025454","article-title":"Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after >\/=2 prior therapies","volume":"145","author":"Sehn","year":"2025","journal-title":"Blood"},{"issue":"10466","key":"10.1016\/j.ijid.2025.108231_bib0005","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(24)01774-4","article-title":"Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial","volume":"404","author":"Abramson","year":"2024","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ijid.2025.108231_bib0006","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa2115304","article-title":"Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma","volume":"386","author":"Tilly","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2025.108231_bib0007","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2024015274","article-title":"Indirect comparison of epcoritamab vs chemoimmunotherapy, mosunetuzumab, or odronextamab in follicular lymphoma","author":"Danilov","year":"2025","journal-title":"Blood Adv"},{"issue":"11","key":"10.1016\/j.ijid.2025.108231_bib0008","doi-asserted-by":"crossref","first-page":"ofac574","DOI":"10.1093\/ofid\/ofac574","article-title":"Cumulative Incidence and Relative Risk of Infection in Patients With Multiple Myeloma Treated With Anti-CD38 Monoclonal Antibody-Based Regimens: A Systematic Review and Meta-analysis","volume":"9","author":"Vassilopoulos","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijid.2025.108231_bib0009","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2024015406","article-title":"Impact of SARS-CoV-2 infection on bispecific antibody treatment in patients with B-cell lymphoproliferative disorders","author":"Serna","year":"2025","journal-title":"Blood Adv."},{"issue":"10","key":"10.1016\/j.ijid.2025.108231_bib0010","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jtct.2024.07.018","article-title":"Best Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management After Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies","volume":"30","author":"Shahid","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.ijid.2025.108231_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(25)00069-6","article-title":"Recommendations from the 10th European Conference on Infections in Leukaemia for the management of cytomegalovirus in patients after allogeneic haematopoietic cell transplantation and other T-cell-engaging therapies","author":"Ljungman","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2025.108231_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/v17010133","article-title":"Herpesvirus Infections After Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies: A Review","volume":"17","author":"Sassine","year":"2025","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.ijid.2025.108231_bib0013","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/cid\/ciae321","article-title":"Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum","volume":"79","author":"Ljungman","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"14","key":"10.1016\/j.ijid.2025.108231_bib0014","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1182\/bloodadvances.2023012175","article-title":"Late cytomegalovirus disease after hematopoietic cell transplantation: significance of novel transplantation techniques","volume":"8","author":"Sadowska-Klasa","year":"2024","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.ijid.2025.108231_bib0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/cid\/civ215","article-title":"Reduced Mortality of Cytomegalovirus Pneumonia After Hematopoietic Cell Transplantation Due to Antiviral Therapy and Changes in Transplantation Practices","volume":"61","author":"Erard","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ijid.2025.108231_bib0016","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ijid.2025.108231_bib0017","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1007\/s00277-025-06344-8","article-title":"Alemtuzumab for haematological malignancies","volume":"104","author":"An","year":"2025","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ijid.2025.108231_bib0018","doi-asserted-by":"crossref","DOI":"10.1007\/s00277-025-06438-3","article-title":"Efficacy and safety of Glofitamab in patients with R\/R DLBCL in real life setting- a retrospective study","author":"Gurion","year":"2025","journal-title":"Ann Hematol"},{"issue":"17","key":"10.1016\/j.ijid.2025.108231_bib0019","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1182\/bloodadvances.2023012234","article-title":"CMV reactivation during pretransplantation evaluation: a novel risk factor for posttransplantation CMV reactivation","volume":"8","author":"Zamora","year":"2024","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.ijid.2025.108231_bib0020","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40635-024-00624-9","article-title":"Epstein-Barr virus, Cytomegalovirus, and Herpes Simplex-1\/2 reactivations in critically ill patients with COVID-19","volume":"12","author":"Mattei","year":"2024","journal-title":"Intensive Care Med Exp"},{"issue":"1","key":"10.1016\/j.ijid.2025.108231_bib0021","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28337","article-title":"Viral reactivation in the lungs of patients with severe pneumonia is associated with increased mortality, a multicenter, retrospective study","volume":"95","author":"Huang","year":"2023","journal-title":"J Med Virol"},{"issue":"11","key":"10.1016\/j.ijid.2025.108231_bib0022","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.bbmt.2017.07.025","article-title":"Cytomegalovirus Reactivation Is Associated with Increased Risk of Late-Onset Invasive Fungal Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Study in the Current Era of Viral Load Monitoring","volume":"23","author":"Yong","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.ijid.2025.108231_bib0023","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1038\/s41598-023-27465-y","article-title":"Incidence and risk factors of opportunistic infections after autologous stem cell transplantation: a nationwide, population-based cohort study in Korea","volume":"13","author":"Kim","year":"2023","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.ijid.2025.108231_bib0024","doi-asserted-by":"crossref","first-page":"ofaf127","DOI":"10.1093\/ofid\/ofaf127","article-title":"Outcomes and Risk Factors for Influenza and Respiratory Syncytial Virus Lower Respiratory Tract Infections and Mortality in Patients With Lymphoma or Multiple Myeloma: A 7-Year Retrospective Cohort Study","volume":"12","author":"Shafat","year":"2025","journal-title":"Open Forum Infect Dis"},{"issue":"Suppl 3","key":"10.1016\/j.ijid.2025.108231_bib0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.rxeng.2022.12.001","article-title":"Basic HRCT patterns in diffuse interstitial lung disease","volume":"64","author":"Gimenez Palleiro","year":"2022","journal-title":"Radiologia (Engl Ed)"},{"issue":"12","key":"10.1016\/j.ijid.2025.108231_bib0026","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.bbmt.2016.08.023","article-title":"Decline in the Use of Surgical Biopsy for Diagnosis of Pulmonary Disease in Hematopoietic Cell Transplantation Recipients in an Era of Improved Diagnostics and Empirical Therapy","volume":"22","author":"Cheng","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.ijid.2025.108231_bib0027","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1093\/infdis\/jix048","article-title":"Cytomegalovirus (CMV) DNA Quantitation in Bronchoalveolar Lavage Fluid From Hematopoietic Stem Cell Transplant Recipients With CMV Pneumonia","volume":"215","author":"Boeckh","year":"2017","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.ijid.2025.108231_bib0028","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jinf.2019.02.009","article-title":"Pulmonary cytomegalovirus (CMV) DNA shedding in allogeneic hematopoietic stem cell transplant recipients: Implications for the diagnosis of CMV pneumonia","volume":"78","author":"Pinana","year":"2019","journal-title":"J Infect"},{"issue":"6","key":"10.1016\/j.ijid.2025.108231_bib0029","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1002\/jmv.26649","article-title":"Comparing cytomegalovirus diagnostics by cell culture and quantitative nucleic acid testing in broncho-alveolar lavage fluids","volume":"93","author":"Leuzinger","year":"2021","journal-title":"J Med Virol"},{"issue":"1","key":"10.1016\/j.ijid.2025.108231_bib0030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12185-024-03770-8","article-title":"Cytomegalovirus infection during daratumumab therapy in patients with newly diagnosed multiple myeloma","volume":"120","author":"Kikuchi","year":"2024","journal-title":"Int J Hematol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225004539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225004539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T18:51:35Z","timestamp":1783018295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971225004539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":30,"alternative-id":["S1201971225004539"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108231","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytomegalovirus DNAemia in the lower respiratory tract in nontransplant patients with hematologic malignancies","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108231"}}